Signaling mechanisms in mammalian myoblast fusion

Science Signaling

Volumn 6, Issue 272, 2013, Pages

  Hindi, Sajedah M ^a   Tajrishi, Marjan M ^a   Kumar, Ashok ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BETA1 INTEGRIN; CALCINEURIN; CAVEOLIN 3; CELL PROTEIN; FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; KRUPPEL LIKE FACTOR 2; KRUPPEL LIKE FACTOR 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOD PROTEIN; PROTEIN CDC42; PROTEIN KINASE C THETA; RAC1 PROTEIN; RAC2 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN;

CELL DIFFERENTIATION; CELL FUSION; CELL GROWTH; CELL LINEAGE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CYTOSKELETON; HUMAN; INTRACELLULAR SIGNALING; MAMMAL CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STEM CELL;

ANIMALS; CALCIUM; CELL FUSION; CELL MEMBRANE; GIANT CELLS; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MYOBLASTS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84876827016     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003832     Document Type: Review

References (84)

1. S. M. Abmayr, G. K. Pavlath, Myoblast fusion: Lessons from flies and mice. Development 139, 641-656 (2012).
2. K. Rochlin, S. Yu, S. Roy, M. K. Baylies, Myoblast fusion: When it takes more to make one. Dev. Biol. 341, 66-83 (2010).
3. G. K. Pavlath, Spatial and functional restriction of regulatory molecules during mammalian myoblast fusion. Exp. Cell Res. 316, 3067-3072 (2010).
4. R. S. Krauss, Regulation of promyogenic signal transduction by cell-cell contact and adhesion. Exp. Cell Res. 316, 3042-3049 (2010).
5. M. Schwander, M. Leu, M. Stumm, O. M. Dorchies, U. T. Ruegg, J. Schittny, U. Müller, Beta1 integrins regulate myoblast fusion and sarcomere assembly. Dev. Cell 4, 673-685 (2003).
6. M. D. Schaller, Cellular functions of FAK kinases: Insight into molecular mechanisms and novel functions. J. Cell Sci. 123, 1007-1013 (2010).
7. N. L. Quach, S. Biressi, L. F. Reichardt, C. Keller, T. A. Rando, Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion. Mol. Biol. Cell 20, 3422-3435 (2009).
8. L. Madaro, V. Marrocco, P. Fiore, P. Aulino, P. Smeriglio, S. Adamo, M. Molinaro, M. Bouché, PKCθ signaling is required for myoblast fusion by regulating the expression of caveolin-3 and β1D integrin upstream focal adhesion kinase. Mol. Biol. Cell 22, 1409-1419 (2011).
9. M. De Vries, H. M. Cooper, Emerging roles for neogenin and its ligands in CNS development. J. Neurochem. 106, 1483-1492 (2008).
10. G. U. Bae, Y. J. Yang, G. Jiang, M. Hong, H. J. Lee, M. Tessier-Lavigne, J. S. Kang, R. S. Krauss, Neogenin regulates skeletal myofiber size and focal adhesion kinase and extracellular signal-regulated kinase activities in vivo and in vitro. Mol. Biol. Cell 20, 4920-4931 (2009).
11. D. Ilić, Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada, T. Yamamoto, Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544 (1995).
12. C. Grabbe, C. G. Zervas, T. Hunter, N. H. Brown, R. H. Palmer, Focal adhesion kinase is not required for integrin function or viability in Drosophila. Development 131, 5795-5805 (2004).
13. D. Yaffe, O. Saxel, Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727 (1977).
14. H. M. Blau, C. P. Chiu, C. Webster, Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32, 1171-1180 (1983).
15. M. Meriane, P. Roux, M. Primig, P. Fort, C. Gauthier-Rouvière, Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: Antagonistic effects of JNK and p38 pathways. Mol. Biol. Cell 11, 2513-2528 (2000).
16. S. Charrasse, M. Meriane, F. Comunale, A. Blangy, C. Gauthier- Rouvière, N-cadherin-dependent cell-cell contact regulates Rho GTPases and beta-catenin localization in mouse C2C12 myoblasts. J. Cell Biol. 158, 953-965 (2002).
17. K. Iwasaki, K. Hayashi, T. Fujioka, K. Sobue, Rho/ Rho-associated kinase signal regulates myogenic differentiation via myocardin-related transcription factor-A/Smad-dependent transcription of the Id3 gene. J. Biol. Chem. 283, 21230-21241 (2008).
18. J. S. Kang, G. U. Bae, M. J. Yi, Y. J. Yang, J. E. Oh, G. Takaesu, Y. T. Zhou, B. C. Low, R. S. Krauss, A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta MAPK activity and myogenic differentiation. J. Cell Biol. 182, 497-507 (2008).
19. B. A. Bryan, D. Li, X. Wu, M. Liu, The Rho family of small GTPases: Crucial regulators of skeletal myogenesis. Cell. Mol. Life Sci. 62, 1547-1555 (2005).
20. L. Wei, W. Zhou, J. D. Croissant, F. E. Johansen, R. Prywes, A. Balasubramanyam, R. J. Schwartz, RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. J. Biol. Chem. 273, 30287-30294 (1998).
21. S. Charrasse, F. Comunale, Y. Grumbach, F. Poulat, A. Blangy, C. Gauthier-Rouvière, RhoA GTPase regulates M-cadherin activity and myoblast fusion. Mol. Biol. Cell 17, 749-759 (2006).
22. M. Fortier, F. Comunale, J. Kucharczak, A. Blangy, S. Charrasse, C. Gauthier-Rouvière, RhoE controls myoblast alignment prior fusion through RhoA and ROCK. Cell Death Differ. 15, 1221-1231 (2008).
23. J. T. Doherty, K. C. Lenhart, M. V. Cameron, C. P. Mack, F. L. Conlon, J. M. Taylor, Skeletal muscle differentiation and fusion are regulated by the BAR-containing Rho-GTPase-activating protein (Rho-GAP), GRAF1. J. Biol. Chem. 286, 25903- 25921 (2011).
24. S. Hakeda-Suzuki, J. Ng, J. Tzu, G. Dietzl, Y. Sun, M. Harms, T. Nardine, L. Luo, B. J. Dickson, Rac function and regulation during Drosophila development. Nature 416, 438-442 (2002).
25. E. Vasyutina, B. Martarelli, C. Brakebusch, H. Wende, C. Birchmeier, The small G-proteins Rac1 and Cdc42 are essential for myoblast fusion in the mouse. Proc. Natl. Acad. Sci. U.S.A. 106, 8935-8940 (2009).
26. E. Rushton, R. Drysdale, S. M. Abmayr, A. M. Michelson, M. Bate, Mutations in a novel gene, myoblast city, provide evidence in support of the founder cell hypothesis for Drosophila muscle development. Development 121, 1979-1988 (1995).
27. M. R. Erickson, B. J. Galletta, S. M. Abmayr, Drosophila myoblast city encodes a conserved protein that is essential for myoblast fusion, dorsal closure, and cytoskeletal organization. J. Cell Biol. 138, 589-603 (1997).
28. K. M. Nolan, K. Barrett, Y. Lu, K. Q. Hu, S. Vincent, J. Settleman, Myoblast city, the Drosophila homolog of DOCK180/CED-5, is required in a Rac signaling pathway utilized for multiple developmental processes. Genes Dev. 12, 3337-3342 (1998).
29. J. F. Côté, K. Vuori, Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J. Cell Sci. 115, 4901-4913 (2002).
30. C. A. Moore, C. A. Parkin, Y. Bidet, P. W. Ingham, A role for the Myoblast city homologues Dock1 and Dock5 and the adaptor proteins Crk and Crk-like in zebrafish myoblast fusion. Development 134, 3145-3153 (2007).
31. M. Laurin, N. Fradet, A. Blangy, A. Hall, K. Vuori, J. F. Côté, The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo. Proc. Natl. Acad. Sci. U.S.A. 105, 15446-15451 (2008).
32. S. P. O'Brien, K. Seipel, Q. G. Medley, R. Bronson, R. Segal, M. Streuli, Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos. Proc. Natl. Acad. Sci. U.S.A. 97, 12074-12078 (2000).
33. S. Charrasse, F. Comunale, M. Fortier, E. Portales- Casamar, A. Debant, C. Gauthier-Rouvière, M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion. Mol. Biol. Cell 18, 1734-1743 (2007).
34. L. Chang, M. Karin, Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
35. Z. Wu, P. J. Woodring, K. S. Bhakta, K. Tamura, F. Wen, J. R. Feramisco, M. Karin, J. Y. Wang, P. L. Puri, p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20, 3951-3964 (2000).
36. E. Perdiguero, V. Ruiz-Bonilla, L. Gresh, L. Hui, E. Ballestar, P. Sousa-Victor, B. Baeza-Raja, M. Jardí, A. Bosch-Comas, M. Esteller, C. Caelles, A. L. Serrano, E. F. Wagner, P. Muñoz-Cánoves, Genetic analysis of p38 MAP kinases in myogenesis: Fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J. 26, 1245-1256 (2007).
37. S. Bhatnagar, A. Kumar, D. Y. Makonchuk, H. Li, A. Kumar, Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation. J. Biol. Chem. 285, 6401-6411 (2010).
38. N. C. Jones, Y. V. Fedorov, R. S. Rosenthal, B. B. Olwin, ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J. Cell. Physiol. 186, 104- 115 (2001).
39. L. L. Tortorella, D. J. Milasincic, P. F. Pilch, Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J. Biol. Chem. 276, 13709-13717 (2001).
40. E. Gredinger, A. N. Gerber, Y. Tamir, S. J. Tapscott, E. Bengal, Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 273, 10436-10444 (1998).
41. D. Dinev, B. W. Jordan, B. Neufeld, J. D. Lee, D. Lindemann, U. R. Rapp, S. Ludwig, Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2, 829-834 (2001).
42. K. Sunadome, T. Yamamoto, M. Ebisuya, K. Kondoh, A. Sehara-Fujisawa, E. Nishida, ERK5 regulates muscle cell fusion through Klf transcription factors. Dev. Cell 20, 192-205 (2011).
43. R. Brandenberger, A. Schmidt, J. Linton, D. Wang, C. Backus, S. Denda, U. Müller, L. F. Reichardt, Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J. Cell Biol. 154, 447-458 (2001).
44. B. Constantin, C. Cognard, G. Raymond, Myoblast fusion requires cytosolic calcium elevation but not activation of voltage-dependent calcium channels. Cell Calcium 19, 365-374 (1996).
45. 2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc. Natl. Acad. Sci. U.S.A. 97, 7627-7632 (2000).
46. K. S. Shin, J. Y. Park, D. B. Ha, C. H. Chung, M. S. Kang, Involvement of K(Ca) channels and stretch-activated channels in calcium infl ux, triggering membrane fusion of chick embryonic myoblasts. Dev. Biol. 175, 14-23 (1996).
47. H. Wu, A. Peisley, I. A. Graef, G. R. Crabtree, NFAT signaling and the invention of vertebrates. Trends Cell Biol. 17, 251-260 (2007).
48. V. Horsley, G. K. Pavlath, NFAT: Ubiquitous regulator of cell differentiation and adaptation. J. Cell Biol. 156, 771-774 (2002).
49. V. Horsley, B. B. Friday, S. Matteson, K. M. Kegley, J. Gephart, G. K. Pavlath, Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J. Cell Biol. 153, 329-338 (2001).
50. V. Horsley, K. M. Jansen, S. T. Mills, G. K. Pavlath, IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483-494 (2003).
51. A. R. Demonbreun, K. A. Lapidos, K. Heretis, S. Levin, R. Dale, P. Pytel, E. C. Svensson, E. M. McNally, Myoferlin regulation by NFAT in muscle injury, regeneration and repair. J. Cell Sci. 123, 2413-2422 (2010).
52. V. Horsley, G. K. Pavlath, Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 161, 111-118 (2003).
53. G. K. Pavlath, V. Horsley, Cell fusion in skeletal muscle-Central role of NFATC2 in regulating muscle cell size. Cell Cycle 2, 420-423 (2003).
54. M. D. Mavalli, D. J. DiGirolamo, Y. Fan, R. C. Riddle, K. S. Campbell, T. van Groen, S. J. Frank, M. A. Sperling, K. A. Esser, M. M. Bamman, T. L. Clemens, Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 120, 4007-4020 (2010).
55. A. Sotiropoulos, M. Ohanna, C. Kedzia, R. K. Menon, J. J. Kopchick, P. A. Kelly, M. Pende, Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc. Natl. Acad. Sci. U.S.A. 103, 7315-7320 (2006).
56. A. Guerci, C. Lahoute, S. Hébrard, L. Collard, D. Graindorge, M. Favier, N. Cagnard, S. Batonnet- Pichon, G. Précigout, L. Garcia, D. Tuil, D. Daegelen, A. Sotiropoulos, Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 15, 25-37 (2012).
57. M. S. Hayden, S. Ghosh, Signaling to NF-kappaB. Genes Dev. 18, 2195-2224 (2004).
58. H. Li, S. Malhotra, A. Kumar, Nuclear factor-kappa B signaling in skeletal muscle atrophy. J. Mol. Med. 86, 1113-1126 (2008).
59. E. Varfolomeev, J. W. Blankenship, S. M. Wayson, A. V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J. N. Dynek, L. O. Elliott, H. J. Wallweber, J. A. Flygare, W. J. Fairbrother, K. Deshayes, V. M. Dixit, D. Vucic, IAP antagonists induce auto-ubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669-681 (2007).
60. B. Razani, A. D. Reichardt, G. Cheng, Non-canonical NF-κB signaling activation and regulation: Principles and perspectives. Immunol. Rev. 244, 44-54 (2011).
61. B. J. Zarnegar, Y. Wang, D. J. Mahoney, P. W. Dempsey, H. H. Cheung, J. He, T. Shiba, X. Yang, W. C. Yeh, T. W. Mak, R. G. Korneluk, G. Cheng, Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378 (2008).
62. S. Vallabhapurapu, A. Matsuzawa, W. Zhang, P. H. Tseng, J. J. Keats, H. Wang, D. A. Vignali, P. L. Bergsagel, M. Karin, Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol. 9, 1364-1370 (2008).
63. N. Bakkar, J. Wang, K. J. Ladner, H. Wang, J. M. Dahlman, M. Carathers, S. Acharyya, M. A. Rudnicki, A. D. Hollenbach, D. C. Guttridge, IKK/ NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180, 787-802 (2008).
64. E. K. Enwere, J. Holbrook, R. Lejmi-Mrad, J. Vineham, K. Timusk, B. Sivaraj, M. Isaac, D. Uehling, R. Al-awar, E. LaCasse, R. G. Korneluk, TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway. Sci. Signal. 5, ra75 (2012).
65. N. Bakkar, K. Ladner, B. D. Canan, S. Liyanarachchi, N. C. Bal, M. Pant, M. Periasamy, Q. Li, P. M. Janssen, D. C. Guttridge, IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J. Cell Biol. 196, 497-511 (2012).
66. H. Li, A. Mittal, P. K. Paul, M. Kumar, D. S. Srivastava, S. C. Tyagi, A. Kumar, Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen- activated protein kinase: A potential role of MMP-9 in myopathy. J. Biol. Chem. 284, 4439- 4450 (2009).
67. M. Girgenrath, S. Weng, C. A. Kostek, B. Browning, M. Wang, S. A. Brown, J. A. Winkles, J. S. Michaelson, N. Allaire, P. Schneider, M. L. Scott, Y. M. Hsu, H. Yagita, R. A. Flavell, J. B. Miller, L. C. Burkly, T. S. Zheng, TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 25, 5826-5839 (2006).
68. C. Dogra, S. L. Hall, N. Wedhas, T. A. Linkhart, A. Kumar, Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. J. Biol. Chem. 282, 15000-15010 (2007).
69. C. Dogra, H. Changotra, S. Mohan, A. Kumar, Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J. Biol. Chem. 281, 10327-10336 (2006).
70. C. Dogra, H. Changotra, N. Wedhas, X. Qin, J. E. Wergedal, A. Kumar, TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle- wasting cytokine. FASEB J. 21, 1857-1869 (2007).
71. A. Mittal, S. Bhatnagar, A. Kumar, P. K. Paul, S. Kuang, A. Kumar, Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice. Am. J. Pathol. 177, 1732-1742 (2010).
72. R. Morosetti, C. Gliubizzi, C. Sancricca, A. Broccolini, T. Gidaro, M. Lucchini, M. Mirabella, TWEAK in inclusion-body myositis muscle: Possible pathogenic role of a cytokine inhibiting myogenesis. Am. J. Pathol. 180, 1603-1613 (2012).
73. C. Roos, A. Wicovsky, N. Müller, S. Salzmann, T. Rosenthal, H. Kalthoff, A. Trauzold, A. Seher, F. Henkler, C. Kneitz, H. Wajant, Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway. J. Immunol. 185, 1593-1605 (2010).
74. H. Huang, X. He, Wnt/beta-catenin signaling: New (and old) players and new insights. Curr. Opin. Cell Biol. 20, 119-125 (2008).
75. J. von Maltzahn, N. C. Chang, C. F. Bentzinger, M. A. Rudnicki, Wnt signaling in myogenesis. Trends Cell Biol. 22, 602-609 (2012).
76. A. Rochat, A. Fernandez, M. Vandromme, J. P. Molès, T. Bouschet, G. Carnac, N. J. Lamb, Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol. Biol. Cell 15, 4544-4555 (2004).
77. N. A. Pansters, J. L. van der Velden, M. C. Kelders, H. Laeremans, A. M. Schols, R. C. Langen, Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β. Cell. Mol. Life Sci. 68, 523-535 (2011).
78. T. H. Tran, X. Shi, J. Zaia, X. Ai, Heparan sulfate 6-O-endosulfatases (Sulfs) coordinate the Wnt signaling pathways to regulate myoblast fusion during skeletal muscle regeneration. J. Biol. Chem. 287, 32651-32664 (2012).
79. A. S. Brack, I. M. Conboy, M. J. Conboy, J. Shen, T. A. Rando, A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2, 50-59 (2008).
80. A. Langsdorf, A. T. Do, M. Kusche-Gullberg, C. P. Emerson Jr., X. Ai, Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev. Biol. 311, 464-477 (2007).
81. E. N. Olson, E. Sternberg, J. S. Hu, G. Spizz, C. Wilcox, Regulation of myogenic differentiation by type beta transforming growth factor. J. Cell Biol. 103, 1799-1805 (1986).
82. D. Han, H. Zhao, C. Parada, J. G. Hacia, P. Bringas, Jr, Y. Chai, A TGFβ-Smad4-Fgf6 signaling cascade controls myogenic differentiation and myoblast fusion during tongue development. Development 139, 1640-1650 (2012).
83. K. H. Lee, M. Y. Baek, K. Y. Moon, W. K. Song, C. H. Chung, D. B. Ha, M. S. Kang, Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269, 14371-14374 (1994).
84. J. M. Dahlman, N. Bakkar, W. He, D. C. Guttridge, NF-kappaB functions in stromal fi broblasts to regulate early postnatal muscle development. J. Biol. Chem. 285, 5479-5487 (2010).